Diabetic Nephropathy - Pipeline Insight, 2018

SKU ID : DEL-11679691 | Publishing Date : 01-Jan-2018 | No. of pages : 90

Detailed TOC of Diabetic Nephropathy - Pipeline Insight, 2018

1. Report Introduction
2. Diabetic Nephropathy Overview
3. Pipeline Therapeutics
• An Overview of Pipeline Products for Diabetic Nephropathy
4. Comparative Analysis
5. Products in Clinical Stage
5.1 Drug Name : Company Name
• Product Description
• Research and Development
• Product Development Activities
6. Products in Pre-Clinical and Discovery Stage
6.1 Drug Name : Company Name
• Product Description
• Research and Development
• Product Development Activities
7. Therapeutic Assessment
• Assessment by Route of Administration
• Assessment by Stage and Route of Administration
• Assessment by Molecule Type
• Assessment by Stage and Molecule Type
8. Inactive Products
8.1 Drug Name : Company Name
• Product Description
• Research and Development
• Product Development Activities
Appendix
Report Methodology
Consulting Services
Disclaimer
About DelveInsight

List of Figures, Tables and Charts Available in Diabetic Nephropathy - Pipeline Insight, 2018

Table 1: Total Products for Diabetic Nephropathy
Table 2: Products in Clinical Stage
Table 3: Products in Non-clinical Stage
Table 4: Assessment by Route of Administration
Table 5: Assessment by Stage and Route of Administration
Table 6: Assessment by Molecule Type
Table 7: Assessment by Stage and Molecule Type
Table 8: Inactive Products


Figure 1: Total Products for Diabetic Nephropathy
Figure 2: Products in Clinical Stage
Figure 3: Products in Non-clinical Stage
Figure 4: Assessment by Route of Administration
Figure 5: Assessment by Stage and Route of Administration
Figure 6: Assessment by Molecule Type
Figure 7: Assessment by Stage and Molecule Type
Figure 8: Inactive Products

Keyplayers in Diabetic Nephropathy - Pipeline Insight, 2018

AbbVie Inc
Allergan Plc
Antisense Therapeutics Ltd
Aptevo Therapeutics Inc
Araim Pharmaceuticals Inc
Arena Pharmaceuticals Inc
AstraZeneca Plc
Bayer AG
BLR Bio LLC
Boehringer Ingelheim GmbH
Cellmid Ltd
ChemoCentryx Inc
CSL Ltd
Daiichi Sankyo Company Ltd
& list continues...
PRICE
2000
6000


  • market Reports market Reports